Effects of Triamcinolone Acetonide and Anecortave Acetate on Uveal Melanoma Cells
Author Information
Author(s): Mariam el Filali, Irene Homminga, Willem van der Velden, Pieter A. Jager, Martine J. Jager
Primary Institution: Leiden University Medical Centre
Hypothesis
Do Triamcinolone Acetonide (TA) and Anecortave Acetate (AA) affect the growth of uveal melanoma cells after radiotherapy?
Conclusion
TA and AA do not stimulate uveal melanoma cell growth, suggesting they are safe for treating radiation retinopathy.
Supporting Evidence
- TA and AA did not induce cell death in uveal melanoma cells.
- No significant effect of TA or AA on cell proliferation was observed.
- TA had an inhibiting effect on TSP-1 expression in one cell line.
Takeaway
The study tested two drugs to see if they help or hurt eye cancer cells, and found that they don't make the cancer cells grow.
Methodology
Three uveal melanoma cell lines were treated with TA or AA, and cell proliferation was measured using the WST-1 assay.
Limitations
The study used a limited number of cell lines, and the clinical dose of TA could not be tested due to crystal deposits.
Statistical Information
P-Value
p=0.755, p=0.844, p=0.487
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website